Browsing by Author Szer, J

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2011How we mobilize haemopoietic stem cellsGottlieb, David; Rasko, John; Cooney, Julian P.; Herbert, Kirsten; Levesque, Jean-Pierre; Mills, A; Szer, J; To, L; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Centenary InstituteHow we mobilize haemopoietic stem cells, Internal Medicine Journal (Print), vol.41, 8, 2011,pp 588-594
2016Interruption of enzyme replacement therapy in Gaucher diseaseWilson, Meredith; Fletcher, Janice; Goldblatt, Jack; McGill, Jim J.; Szer, J; Childrens Hospital Westmead: Paediatrics & Child HealthInterruption of enzyme replacement therapy in Gaucher disease, SAMJ South African Medical Journal, vol.106, 6, 2016,pp S79-S81
2016Interruption of enzyme replacement therapy in Gaucher diseaseWilson, Meredith; Fletcher, Janice; Goldblatt, Jack; McGill, Jim J.; Szer, J; Childrens Hospital Westmead: Paediatrics & Child HealthInterruption of enzyme replacement therapy in Gaucher disease, SAMJ South African Medical Journal, vol.106, 6, 2016,pp S79-S81
2015Oral chronic graft-versus-host disease in Australia: Clinical features and challenges in managementKerridge, Ian; Avery, S; Hull, K; McCullough, M; Ritchie, David S; Szer, J; School of Public Health: Ctr for Values Ethics & Law in MedOral chronic graft-versus-host disease in Australia: Clinical features and challenges in management, Internal Medicine Journal, vol.45, 7, 2015,pp 702-710
2015Oral chronic graft-versus-host disease in Australia: Clinical features and challenges in managementKerridge, Ian; Avery, S; Hull, K; McCullough, M; Ritchie, David S; Szer, J; School of Public Health: Ctr for Values Ethics & Law in MedOral chronic graft-versus-host disease in Australia: Clinical features and challenges in management, Internal Medicine Journal, vol.45, 7, 2015,pp 702-710
2004Oral Versus Intravenous Ganciclovir For The Prophylaxis Of Cytomegalovirus Disease After Allogeneic Bone Marrow Transplantation.Bradstock, Kenneth; Gibson, John; Arthur, C; Durrant, S; Hughes, T; Raunow, H; Schwarer, A P; Szer, J; To, L B; Western Clinical School: Westmead Millennium Institute; Central Clinical School: MedicineOral Versus Intravenous Ganciclovir For The Prophylaxis Of Cytomegalovirus Disease After Allogeneic Bone Marrow Transplantation., Internal Medicine Journal 2005, vol.34,(3),2004,pp 98-101
2015Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: Position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupGibson, John; Ho, Joy Phoebe; Joshua, Douglas; Augustson, Bradley M.; Brown, R. D.; Catley, Andrew; Harrison, Simon James; Horvath, Noemi; Jaksic, M; Mollee, P.; Prince, H.Miles; Quach, Hang; Roberts, A W; Spencer, A.; Szer, J; Talulikar, D; To, KF; Zannettino, A; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineTreatment of patients with multiple myeloma who are eligible for stem cell transplantation: Position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group, Internal Medicine Journal, vol.45, 1, 2015,pp 94-105